A lifesaving drug will remain accessible to patients struggling with cancer and endometriosis.

Breast cancer patients were considering removing their ovaries until the maker of Zoladex 3.6mg said they would give the drug away rather than list it on the PBS.

AstraZeneca's Zoladex reversal has left some patients with more questions than answers.